ONCO Onconetix Corp: Prakiraan wutah bathi resik saben saham kanggo taun ngarep

Onconetix Corp - logo grafis emiten ONCO

Onconetix, Inc. (ONCO) maintains solid authority in the fields of urology and oncodiagnostics. The forward-looking earnings per share growth forecast reflects an expert consensus, with the latest figure standing at 0.00. Streamlined logistics ensure stable supplies to medical centers. However, the company relies on regulatory approvals amid limited liquidity and significant drug promotion expenses.

Onconetix Inc (ONCO): Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep saka 21.02.2024 nganti 16.11.2026

Rincian metrik lan analitis perusahaan Onconetix Inc (ONCO)

- data kapitalisasi saham perusahaan:
Analisis umum perusahaan:Onconetix Inc, ONCO
Barang utama Onconetix

This metric assesses future operating efficiency through aggregated expert expectations for earnings per share, signaling capitalization potential. The trend in the projected growth rate of net income per share reflects the resilience of Onconetix, Inc. (ONCO) to regulatory risks and raw material supply disruptions, allowing investors to determine safe valuation ranges for the asset amid geopolitical instability.

Pesaing Onconetix, Inc.

A (agilent.com) - Prakiraan wutah bathi kanggo taun ngarep|DGX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|EXAS - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep RVTY (revvity.com)|Bio-Rad Laboratories (BIO) - Prakiraan wutah bathi resik saben saham ing taun ngarep|Anbio Biotechnology - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep soterahealth.com|QDEL: Prakiraan wutah bathi kanggo taun ngarep|OPKO Health - Dinamika bathi saben saham sing diarepake ing taun ngarep|CDNA (CareDx, Inc) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep MRVI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fulgent Genetics (FLGT)|LAB (Standard BioTools Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep CTKB (Cytek Biosciences)|OraSure Technologies Inc (OSUR) - Prakiraan wutah bathi resik saben saham ing taun ngarep|XGN - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|MDxHealth Inc. - Proyeksi tambahing bathi saben saham ing taun ngarep|LUCD: Prakiraan wutah bathi kanggo taun ngarep|Prenetics Global Limited - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insight Molecular Diagnostics, Inc.|trinitybiotech.com (TRIB) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep PRPH|Prakiraan wutah bathi kanggo taun ngarep Ainos Corp (AIMD)|Prakiraan wutah bathi kanggo taun ngarep CODX (codiagnostics.com)|Heart Test Laboratories - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Biomerica Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Cardio Diagnostics Holdings|VRAX (Virax Biolabs Group Ltd) - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Bluejay Diagnostics Corp (BJDX)|AWH (Aspira Women's Health, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|AXDX - Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep centogene.com (CNTG)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Enzo Biochem|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep FRES|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep GTG Labs|23andMe Holding Co - Prakiraan wutah bathi kanggo taun ngarep|PMD - Prakiraan wutah bathi kanggo taun ngarep